Somnomed Ltd
ASX:SOM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Marzetti Co
NASDAQ:MZTI
|
US |
|
Jiangsu Skyray Instrument Co Ltd
SZSE:300165
|
CN |
|
Beijing Lirr High-temperature Materials Co Ltd
SZSE:002392
|
CN |
Somnomed Ltd
Total Equity
Somnomed Ltd
Total Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Somnomed Ltd
ASX:SOM
|
Total Equity
AU$50m
|
CAGR 3-Years
26%
|
CAGR 5-Years
8%
|
CAGR 10-Years
8%
|
|
|
C
|
Cyclopharm Ltd
ASX:CYC
|
Total Equity
AU$27.1m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
10%
|
CAGR 10-Years
8%
|
|
|
Cochlear Ltd
ASX:COH
|
Total Equity
AU$1.9B
|
CAGR 3-Years
4%
|
CAGR 5-Years
3%
|
CAGR 10-Years
17%
|
|
|
Optiscan Imaging Ltd
ASX:OIL
|
Total Equity
AU$22m
|
CAGR 3-Years
64%
|
CAGR 5-Years
16%
|
CAGR 10-Years
N/A
|
|
|
Austco Healthcare Ltd
ASX:AHC
|
Total Equity
AU$58.8m
|
CAGR 3-Years
35%
|
CAGR 5-Years
29%
|
CAGR 10-Years
N/A
|
|
|
EMvision Medical Devices Ltd
ASX:EMV
|
Total Equity
AU$19.7m
|
CAGR 3-Years
36%
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
|
Somnomed Ltd
Glance View
SomnoMed Ltd. produces and sells oral treatment of sleep related disorder devices. The company is headquartered in Sydney, New South Wales. The company went IPO on 2004-08-27. The firm provides treatment solutions for sleep-related breathing disorders, including obstructive sleep apnea, snoring, and bruxism. SomnoMed has developed the SomnoDent, a collection of oral devices. SomnoDent includes two product line, such as signature line and standard line. Its signature line products include Herbst Advance Elite, Fusion, Flex and Classic, and standard line products include Herbst Advance, Air/Air+, Morning Repositioner and Alpha. SomnoMed has developed the SomnoBrux, a custom fit acrylic occlusal splint. SomnoBrux product includes Michigan. SomnoMed has developed the SomGauge, is an autoclavable instrument, which can be used to construct accurate and reliable bite records.
See Also
What is Somnomed Ltd's Total Equity?
Total Equity
50m
AUD
Based on the financial report for Dec 31, 2025, Somnomed Ltd's Total Equity amounts to 50m AUD.
What is Somnomed Ltd's Total Equity growth rate?
Total Equity CAGR 10Y
8%
Over the last year, the Total Equity growth was 5%. The average annual Total Equity growth rates for Somnomed Ltd have been 26% over the past three years , 8% over the past five years , and 8% over the past ten years .
